p53 modulates BLM and WRN helicase activities 2 SUMMARY BLM, WRN and p53 are involved in the homologous DNA recombination pathway. The DNA structure-specific helicases, BLM and WRN, unwind Holliday junctions (HJ), an activity that could suppress inappropriate homologous recombination during DNA replication. Here, we show that purified, recombinant p53 binds to BLM and WRN helicases and attenuates their ability to unwind synthetic HJ in vitro. The p53 248W mutant reduces abilities both to bind HJ and to inhibit helicase activities, whereas the p53 273H mutant losses these abilities. Moreover, fulllength p53 and a C-terminal polypeptide (residues 373-383) inhibit the BLM and WRN helicase activities, but phosphorylation at Ser376 or Ser378 completely abolishes this inhibition.
INTRODUCTION

Bloom and Werner syndromes (BS and WS)
1 are autosomal recessive disorders characterized by immune deficiency, cancer predisposition and chromosomal instability (1) . The products of the genes responsible for these disorders, BLM and WRN, are ATP-dependent DNA helicases that exhibit 3' to 5' polarity. Mutations in the BLM or WRN genes disrupt their helicase activity, which may be important for the phenotypic traits associated with these hereditary diseases (2) .
Homologous recombination (HR) 1 is required for genetic exchange during meiosis, repair of complex lesions in DNA and the segregation of chromosomes at cell division. Expression of the BLM or WRN helicases in S. cerevisiae containing a mutation in sgs1, a BLM and WRN homolog, suppresses their increased rates of illegitimate recombination and HR (3) . BLM and its yeast homologue, Sgs1, functionally interact with topoisomerase III (4) while the WRN interaction with DNA polymerase delta is apparently required for some aspect of DNA replication and/or repair (5, 6) . Recent reports indicate that both of these helicases recognize and disrupt alternative DNA structures, including G-quadruplex DNA and Holliday junctions (HJ) 1 (7) (8) (9) (10) (11) . HJ arise as intermediates during HR and can occur spontaneously, or during DNA replication and the repair of DNA damage (12) . BLM and WRN may promote ATP-dependent translocation of HJ to eliminate DNA recombination intermediates, thereby reducing inappropriate DNA recombination in vivo (10, 11) .
p53 suppresses genomic instability, particularly in response to DNA damage (13, 14) . p53 also has been implicated in HR. Evidence of p53 modulation of HR includes the following: (a) overexpression of wild-type p53 (WTp53) can down-regulate the rate of HR between SV40 molecules (15) ; (b) the rate of HR is increased in p53 mutant cell lines (16) (17) (18) ; (c) p53 has 3' to p53 modulates BLM and WRN helicase activities 4 5' exonuclease and DNA strand transfer activities (19) ; and (d) p53 can bind and inhibit human RAD51 and bacterial RecA, central components of the HR pathway (20, 21) . In vitro, p53 also can bind to the crossover region of HJ (22) , positively or negatively supercoiled DNA (23, 24) , and DNA base mismatches (25) ; all of these structures can be associated with HR.
p53 physically and functionally interacts with BLM and WRN in vivo and in vitro (26) (27) (28) .
We hypothesize that p53 may regulate HR through its modulation of the BLM and WRN helicase activities. In this study, we present the first evidence that p53 modulates the ability of BLM and WRN helicases to disrupt HJ. This property can be altered by modifications to the p53 C-terminus at Ser376 or Ser378. These modifications decrease p53's modulation of recombination and abrogate its binding to BLM. p53-mediated inhibition of BLM or WRN helicase activity apparently occurs through direct binding to these helicases. In addition, we
show that p53 colocalizes in vivo with BLM and RAD51 at putative sites of stalled DNA replication forks and HJ in cells arrested in S-phase by aphidicolin (APH) 1 . These results indicate a possible physiological mechanism for the regulation of HR by the physical and functional interaction of p53 with the BLM and WRN DNA helicases as well as their DNA substrates.
p53 modulates BLM and WRN helicase activities
Experimental Procedures
Cell culture, Western Blot Analyses and ImmunoprecipitationGM01310, a normal human lymphoblastoid cell line (LCL) 1 , was maintained at a density greater than 3 X 10 5 cells/ml in RPMI medium supplemented with 15% fetal bovine serum, penicillin and streptomycin (Biofluids). Human WI-38 and GM08402 fibroblasts were used at early passage. Western blot analysis and immunoprecipitation were performed as described previously (27) .
Proteins and AntibodiesRecombinant hexa-histidine tagged human BLM and WRN proteins were purified as described previously (29, 30) . Human WT, 248W and 273H p53
proteins were generated from recombinant baculoviruses in Sf9 insect cells, and purified using an anti-p53 (antibody PAb421, which recognizes the C-terminus of p53) immunoaffinity column, as described previously (31) . were from UBI. Anti-BLM and anti-WRN were from Santa Cruz (Santa Cruz). PAb421, DO-1, Ser15 phospho-p53 and anti-RAD51 were from Oncogene Research Products.
DNA SubstratesThe synthetic X-junction (four-arm junction, blunt ends, X-12) was prepared by annealing four 50-mer oligonucleotides as described previously (10, 32) . Briefly, X12-1 was 5'-32 P-labeled and annealed with X12-2, X12-3 and X12-4. The product was then purified by separation through a 10% TBE gel, and recovered by electroelution and dialysis. The linear blunt duplex DNA used as the nonspecific competitor was prepared by annealing X12-1 incubated at room temperature for 20 min and fixed in the presence of 0.25% glutaraldehyde for 10 min at 37°C. The products were separated by electrophoresis through 4% nondenaturing polyacrylaminde gels at 4°C for 3 h, and visualized using a PhosphorImager or film autoradiography.
Electron Microscopic Visualization of p53-HJ interaction   HJ substrates (Hol575) for electron microscopy were prepared as described previously (22) . p53-DNA complexes were p53 modulates BLM and WRN helicase activities assembled by incubating 50 ng of DNA in a 50-µl reaction containing 10 mM HEPES (pH 7.5) and 100 mM KCl for 20 min at room temperature using a 1:6 molar ratio of HJ DNAs to p53
tetramers. The complexes were fixed with 0.6% glutaraldehyde (v/v) for 10 min at room temperature followed by gel filtration using a 1 ml Biogel A5m (Bio-Rad) column to remove free protein and fixatives. The samples were prepared for electron microscopy as described previously (34) . Briefly, the samples were adsorbed to thin carbon foils supported by 400-mesh Indirect ImmunofluorescenceCells in 4-well glass chamber slides were cultured with 5 µg/ml APH for 14 h, fixed and stained, as described (4), using anti-BLM, anti-RAD51, and/or Ser15 phospho-p53 antibodies. Images were analyzed by Confocal Assistant software or Laser
Sharp. Quantitation of nuclear foci was determined from 100 cells for each treatment. Data were obtained from at least three independent experiments.
RESULTS
Modulation of the BLM and WRN helicase activities by p53Because the helicase activities
of BLM and WRN are necessary for the promotion of HJ branch migration (10,11), a key step in HR, we investigated the possibility that p53 modulates the ability of BLM and WRN to disrupt a radiolabeled synthetic X-junction (X-12) substrate (blunt ends). This X-junction is a mimic of the HJ. Consistent with previous reports (9-11), both purified recombinant BLM and WRN disrupted the X-junction into one-armed (single-stranded DNA) and, to a lesser extent, into twoarmed products ( showed intrinsic helicase activity (Fig. 1A ).
To determine whether that inhibition of BLM and WRN helicases by p53 is structure-specific, an M13 28-bp partial duplex DNA substrate was incubated with BLM (6 nM) and increasing amounts of p53 (0, 5, 10, 20 nM monomer). As shown in Supplemental data 1, p53 did not inhibit BLM unwinding of the M13 partial duplex. Consistent with a previous report that p53
does not inhibit WRN unwinding of a partial duplex substrate (33) , it suggests that inhibition of BLM and WRN helicases by p53 is structure-specific.
Specificity of BLM, WRN and p53 bound to HJRecombinant p53 protein produced in
baculovirus exists in a tetrameric form and binds to its DNA consensus sites predominantly as a tetramer or as higher molecular weight complexes (36) (37) (38) (39) (40) . We used electrophoretic mobility gel shift assays (EMSA) to determine the specific binding of BLM, WRN or p53 to the X-junction.
Consistent with previous data (10, 11, 22) , BLM induced a single-shifted band, while both WRN and p53 induced multiple-shifted bands ( Fig. 2A) . One possibility is that a single molecule of BLM binds to the X-junction, whereas WRN and p53 bind to this substrate either in different oligomeric states or at multiple sites on the DNA molecule. Whereas WTp53 bound efficiently to the X-junction, 248Wp53 bound to a lesser degree, and 273Hp53 showed no detectable binding activity ( Fig. 2A) . The shifted bands were competed efficiently by the unlabelled X-junction, but not by dsDNA (blunt ends). The simultaneous addition of both p53 and BLM to EMSA reactions resulted in an increased intensity of the shifted bands with different mobility. The presence of both p53 and BLM in these shifted bands was confirmed by Western blot analysis with either p53 or BLM antibody, indicating the presence of a p53-BLM-X-junction complex (Fig. 2B , band 7 and 8). Similar results were obtained when WRN and p53 were used on the EMSA analysis.
Both proteins were detected in the shifted bands (Fig. 2C) .
Electron Microscopic Visualization of p53-HJ interactionTo visualize HJ by electron
microscopy, four-way junctions containing 500 bp arms (Hol575) were constructed as described previously (22) . The Hol575 DNA was incubated with WTp53 as well as the 248Wp53 and 273Hp53 at room temperature for 20 min. The samples were fixed, processed through Biogel A5m to remove free proteins and fixatives, and prepared for EM. Examination of the WTp53 complexes with Hol575 showed that a large number of the HJ DNAs had p53 bound at the crossover point (Fig. 3A) . The DNA molecules were scored (n=300) and the results showed that 63% of the HJ had p53 bound somewhere on the DNA. Of these bound molecules, 70% contained p53 at the crossover point, 13% had protein bound along an arm of the HJ and 17%
had p53 at an end of one arm. The 248Wp53 showed slightly lower binding affinity than the WTp53. Of the molecules scored, 40% of the molecules were bound by p53. In addition, this mutant had lower affinity for the crossover point of the junction. Of the bound molecules counted, only 45% had protein at the crossover junction when compared with 70% in WTp53.
The remaining molecules had p53 bound either along the arm or at the termini of the arms.
Finally, the 273Hp53 mutant showed very low binding to the Hol575 template. Only 12% of the DNA molecules were bound by the protein and, more interestingly, none of the bound molecules had p53 at the crossover point. When compared with the WTp53, this mutant not only had reduced binding to DNA, but also had lost the specificity of the crossover point.
The E. coli RuvA protein specific binds to HJ at the crossover junction (41, 42) . Here, it competed efficiently with WRN or p53 for binding to the X-junction (Fig. 3B ). In the presence of a 3-fold excess of WRN or p53 over RuvA, the RuvA-X-junction complex predominated. This indicated that the affinity of WRN and p53 for the X-junction is less than that observed with
RuvA. Consistent with a previous report (11) , similar results were seen with BLM (data not shown). These data indicate that p53, BLM and WRN recognize the DNA crossover of the HJ.
Relationship between binding to HJ and inhibition of helicase activity by p53Next, we compared the effects of various concentrations of WT, 248W or 273H p53 for their binding to the X-junction and their inhibition of BLM or WRN helicase activity. WTp53 bound to the X-junction and inhibited the helicase activities of BLM and WRN in a dose-dependent manner (Fig. 4) . Binding of the 248Wp53 to the X-junction and inhibition of BLM and WRN helicase activities were dose-dependent, but the magnitude of the effect was reduced significantly relative to that of WTp53. 273Hp53 did not significantly bind to the X-junction nor inhibit helicase activity. Only about 20% of BLM or WRN proteins were immunoprecipitated by these antibodies (data not shown).
In vitro and in vivo interaction
A dilution series of recombinant p53 was used as a standard for quantification of the amount of cellular p53. p53 increased to 3.3 x 10 4 molecules/cell 3 hr after irradiation (Fig. 5A) , whereas the amount of BLM was unchanged under these experimental conditions. Assuming that there are 4,000 molecules of BLM/cell (43), the ratio of p53 to BLM is about 8:1. Previous studies have suggested that active forms of BLM and p53 are hexameric and tetrameric, respectively (30, 36) . Hence, the maximum calculated percentage of p53 that could be immunoprecipitated by anti-BLM antibodies is approximately 12%. We found that about 2% of the cellular p53 was immunoprecipitated by anti-BLM or anti-WRN antibody after exposure to irradiation (Fig. 5B ). (Fig. 5C ).
We next analyzed the binding affinities of WT and mutant p53 to BLM and WRN. Using an ELISA assay, WTp53 and 248Wp53 bound in a dose-dependent manner, and with similar affinities, to both BLM and WRN. In contrast, 273Hp53 showed a relatively weak level of binding to either BLM or WRN (Fig. 5D) . The specificity of the interaction was demonstrated by the absence of detectable signals in wells that had been precoated with BSA only (data not shown).
Modifications to the p53 C-terminus attenuate its inhibition of BLM and WRN helicase
activitiesThe p53 C-terminus is required for binding to both BLM or WRN (26-28) and may be posttranslationally modified (44, 45) . Therefore, we determined whether modification of the p53 C-terminus would alter its ability to modulate the helicase activities of BLM and WRN in a model system. Protein kinase C (PKC) phosphorylates p53 in vitro at Ser378 within the PAb421 antibody epitope, thereby reducing PAb421 reactivity (35, 46) . Protein phosphatase 1 (PP1)
dephosphorylates the PKC-reactive site in p53 (35) . Consistent with these reports, phosphorylation of purified recombinant p53 protein by PKC significantly reduced the reactivity of p53 to PAb421, but not to DO-1, an antibody that targets the N-terminus of p53
(Supplemental data). Incubation of the PKC-treated p53 protein with phosphatase PP1
effectively restored PAb421 reactivity.
The PKC-phosphorylated p53 protein exhibited reduced inhibition of BLM or WRN helicase activity relative to unmodified p53, whereas dephosphorylation of PKC-treated p53 protein by PP1 restored its activity (Figs. 6A and B). With PKC-phosphorylated p53 protein at a concentration of 9 nM, approximately 28% inhibition of BLM and 21% inhibition of WRN helicase activities were observed. Approximately 93% inhibition of both BLM and WRN helicase activities was achieved using dephosphorylated PKC-treated p53, similar to the 94% inhibition seen when using unmodified WTp53. In addition, PAb421, but not DO-1, an antibody to the N-terminus of p53, also blocked the inhibitory effect of p53 on BLM and WRN helicase activities. Compared with 45% inhibition of BLM, the PAb421-p53 complex gave only 12% inhibition of WRN.
To examine whether modification of the p53 C-terminus altered binding to HJ, the binding affinities of PKC-phosphorylated p53 and dephosphorylated PKC-treated p53 to the X-junction were determined by EMSA. The PKC-phosphorylated p53 and dephosphorylated PKC-treated p53 had similar affinities toward the X-junction as unmodified WTp53 (Supplemental data). To explore the mechanism of p53 inhibition of BLM and WRN helicase activities, we examined binding affinities between C-terminal modified p53 and BLM or WRN protein. In agreement with the results of the helicase assays, modification of the recombinant GST-p53 fusion protein, through either PAb421 antibody or PKC phosphorylation, attenuated its ability to bind to BLM or WRN protein (Fig. 6C ).
To further determine the requirement of the p53 C-terminus for the modulation of BLM and WRN helicase activity, a synthetic p53 peptide corresponding to residues 373-383 was used in the helicase assay. This p53 peptide exhibited a concentration-dependent inhibition of BLM and WRN helicase unwinding of the X-junction (Figs. 7A and B) . In contrast, the p53 peptide phosphorylated at Ser376 (P1) or Ser378 (P2) was noninhibitory, even at a high concentration (Figs. 7A and B). These three short peptides did not compete with p53 for binding to the Xjunction, whereas the longer p53 peptide (319-393aa) competed efficiently (Supplemental data).
Taken together, we conclude that a p53 C-terminal region containing residues 373-383 is required for the interaction with and modulation of the branch migration activities of the BLM and WRN helicases on HJ.
p53, BLM and RAD51 colocalize to nuclear fociRAD51 protein catalyzes a key step in HR, and it accumulates in nuclear foci that are thought to correspond to sites of stalled replication forks and recombinational repair of DNA double-strand breaks (47) . BLM and RAD51 form a complex and colocalize to nuclear foci in cells arrested in S-phase using either APH or hydroxyurea (47, 48) , suggesting that these proteins cooperate in the repair of breaks arising at stalled replication forks. The effects of p53 on BLM disruption of HJ presented here suggest that p53 may be involved in this process in vivo. To test this hypothesis, we examined the localization of p53, BLM and RAD51 in cells treated with APH. Cell cycle distribution was determined by flow cytometry (data not shown). Consistent with previous reports (47, 48) , BLM and RAD51 nuclear foci increased and colocalized in S-phase cells after treatment with APH (Fig. 8) . About 45% of the APH-treated cells displayed Ser15 phospho-p53 nuclear foci, but none of the untreated cells did. Quantitative analysis of the confocal microscopic pixels indicated that 63%
and 39% of Ser15 phospho-p53 foci colocalized with BLM and RAD51, respectively (Fig 8B) .
Similarly, Ser15 phospho-p53, BLM and RAD51 were found to colocalize after S-phase arrest in U2OS cells, derived from a human osteogenic sarcoma that contains WTp53 (data not shown).
These colocalization data provide in vivo evidence that p53 may play a role in a recombinational repair pathway that also includes BLM and RAD51. 
Effects of modifications to the p53 C-terminus on helicase activityThe p53 C-terminus
contains several important phosphorylation sites that affect p53-mediated function (44, 45) . For example, p53 can be regulated positively or negatively by reversible PKC modifications in vitro, affecting the latent or active state of the protein (35, 45) , although it is uncertain whether or not PKC phosphorylates p53 in vivo (53) (54) (55) . Certain types of cellular stress, e.g., ionizing irradiation, lead to rapid dephosphorylation of p53 at Ser376 (46, 56) . Recent reports have shown that p53 binds to BLM or WRN in vivo and in vitro and that p53 lacking the C-terminus does not bind to these helicases (26) (27) (28) . Based on the data presented here, the p53 C-terminus is involved in the inhibition of the BLM and WRN helicase activities. p53-mediated inhibition of BLM or WRN helicase activity is reduced by modification of p53 through either the binding of PAb421, a p53 specific antibody that binds to a C-terminal epitope, or the phosphorylation at Ser376 and Ser378, which inhibits its binding to BLM or WRN. Furthermore, a p53 C-terminal polypeptide (residues 373-383) is sufficient to inhibit BLM or WRN helicase activity, while a peptide phosphorylated at Ser376 or Ser378 lacks this activity. Taken together, our data provide direct evidence that posttranslational modification of the p53 C-terminus regulates its interaction with these DNA helicases. The fact that this small C-terminal peptide inhibits helicase activity and that the inhibition can be reversed by phosphorylation indicates that the p53 C-terminus contains an active site. Posttranslational modification of p53 in response to DNA strand breaks may be a molecular switch that regulates the functional interaction between p53 and DNA helicases.
Insight into the mechanism of p53-mediated BLM and WRN helicase activitiesBLM
specifically binds to HJ, but fails to form a stable complex with linear, blunt ended duplex DNA that contains a sequence identical to that of one of the 'arms' of HJ (11) . This indicates that BLM binds strongly to the crossover region of HJ. WRN also binds to HJ (10) . The activity of WRN on recombination intermediates is due, at least in part, to the recognition of the junction within the duplex DNA substrate.
Here, we report that the binding affinity of WTp53 to a mimic of the HJ is higher than that of the 248Wp53 mutant, and that the 273Hp53 lacks this binding ability. to the X-junction by p53 peptides using EMSA.
